• Bestatin (Ubenimex) for Reliable Cell Assays

  2026-09-08

  This scenario-based guide explains how Bestatin (Ubenimex), SKU A2575, can support controlled aminopeptidase inhibition, viability testing, apoptosis assay design, and multidrug resistance research. It connects biochemical potency, stock preparation, assay controls, and vendor-selection criteria to practical laboratory decisions.

• Mitochondrial NAD+ Deficiency in Aortic Aneurysm

  2026-09-07

  The reference study identifies deficient mitochondrial NAD+ salvage and transport in vascular smooth muscle as a causal driver of thoracic and abdominal aortic aneurysm. By integrating human multiomics, genetic association analysis, and smooth-muscle-specific mouse models, it connects SLC25A51 dysfunction to impaired proline supply, collagen III turnover, and aortic wall failure.

• TGF-β, Sca-1, and Mammary Cell Plasticity

  2026-09-07

  This study identifies TGF-β signaling as a regulator of Sca-1 expression, tumorigenic potential, and epithelial plasticity in mouse pre-neoplastic and cancer-associated mammary cells. Its key contribution is the distinction between endogenous Smad2/3/4-dependent repression and exogenous TGF-β-induced Sca-1 loss through a Smad2/3-independent mechanism, providing a useful framework for interpreting dynamic stem-cell markers.

• Caffeine Assay Design: Practical N2379 Guidance

  2026-09-05

  Learn how Caffeine (SKU N2379) can support reproducible cell viability, proliferation, cytotoxicity, and metabolism-focused workflows. This scenario-based guide covers stock preparation, dose selection, VPA combination studies, data interpretation, and practical vendor evaluation.

• NHS-Biotin in Multimeric Protein Translation

  2026-09-04

  Multimeric nanobody assemblies can improve avidity and functional versatility, but translational programs also need reliable ways to track, capture, and compare those assemblies. This article explains how NHS-Biotin can serve as a complementary analytical layer for peptidisc-assisted protein engineering, connecting amine-reactive labeling with reproducible detection, purification, and intracellular research workflows.

• Clarithromycin for CYP3A Interaction Studies

  2026-09-04

  Clarithromycin provides a practical, soluble-in-DMSO tool for modeling CYP3A-mediated drug-drug interactions in microsomes, hepatocytes, and pharmacokinetic assays. Its value is especially clear when statin or cardiovascular disease drug interaction questions are paired with a CYP450-independent comparator such as dabigatran.

• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-09-03

  This 2025 ACS Medicinal Chemistry Letters study used molecular simulation-guided design to discover triazole aldehyde dehydrogenase 2 activators with improved activity and water solubility. Compound Z17 produced strong ALDH2 activation and reduced functional, biochemical, and histological indicators of myocardial ischemia-reperfusion injury in mice, providing a useful preclinical framework rather than clinical proof.

• Trolox Workflows for Oxidative Stress Assays

  2026-09-03

  Trolox provides a practical, cell-permeable benchmark for antioxidant assays, oxidative injury research, and lipid peroxidation workflows. Its strongest value emerges when paired with viability, lipid-ROS, and compartment-specific readouts rather than used as a nonspecific ROS-control reagent alone.

• Irinotecan in Organoid and Xenograft Research

  2026-09-02

  Irinotecan (CPT-11) connects topoisomerase I biology with practical colorectal cancer assays, from cell-line benchmarks to xenograft studies. Its value increases when drug response is tested in patient-relevant organoid and stromal co-culture systems that expose microenvironment-driven resistance.

• GI 254023X: A Selective ADAM10 Inhibitor

  2026-09-02

  GI 254023X provides a practical way to separate ADAM10 sheddase activity from closely related ADAM17 biology in endothelial-barrier and Jurkat-cell experiments. Its value is strongest when target engagement is paired with functional readouts, dose-response design, and the moderate-effect logic highlighted by neurobiology research.

• Superoxide Dismutase Activity Assay Kit Workflow

  2026-09-01

  Build a fast, colorimetric SOD Activity Assay workflow around matrix controls, dilution linearity, and wavelength-specific quality checks. The approach is especially useful for oxidative stress assay development, where SOD activity must be distinguished from direct hydrogen peroxide measurements and probe-specific artifacts.

• Partial BACE Inhibition Preserves Synaptic Transmission

  2026-09-01

  Satir et al. show that modest β-secretase inhibition can reduce amyloid β secretion by up to approximately 50% without measurable impairment of synaptic transmission in cultured rat cortical neurons. The study identifies a dose-dependent separation between potentially useful amyloid reduction and synaptic dysfunction, providing a practical framework for interpreting BACE inhibitor exposure in Alzheimer’s disease prevention studies.

• Lactate–HMGB1 Signaling in Polymicrobial Sepsis

  2026-08-31

  Yang and colleagues identified lactate as an active regulator of macrophage HMGB1 release rather than only a biomarker of severe sepsis. Their work links lactate uptake to HMGB1 lactylation, acetylation, exosomal secretion, endothelial permeability, and survival in polymicrobial sepsis, providing a mechanistic framework for inflammatory signaling pathway research.

• Itraconazole for Candida Biofilm Assays

  2026-08-31

  Itraconazole is a triazole antifungal agent with value beyond growth inhibition. This guide shows how to use its CYP3A4, autophagy, and biofilm-relevant biology to design more discriminating Candida resistance assays.

• circHIF1A Axis and M2 Polarization in LUAD

  2026-08-30

  This study identifies a circHIF1A/miR-486-5p/GRHL2 regulatory axis that connects malignant behavior in lung adenocarcinoma cells with IL-10-associated macrophage M2 polarization. Its combined patient, cellular, and xenograft evidence supports circHIF1A as a candidate prognostic biomarker and highlights circular RNA-mediated remodeling of the tumor immune microenvironment.

7917 records 1/528 page Next 12345 下5页 Last page